Li-ying Jin
Qingdao, 266003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Erratum: Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
Journal: International journal of clinical and experimental pathology
Published: March 04, 2024
Erratum: NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Erratum: NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Journal: International journal of clinical and experimental pathology
Published: February 06, 2024
Erratum: DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt/β-catenin pathway.
Journal: International journal of clinical and experimental pathology
Published: January 30, 2024
DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt/β-catenin pathway.
Journal: International journal of clinical and experimental pathology
Published: November 18, 2018
miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
Journal: Journal of cellular physiology
Published: September 16, 2018
MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: July 21, 2017
Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 05, 2017
Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Journal: Journal of cellular and molecular medicine
Published: January 22, 2016
miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Journal: Journal of cellular and molecular medicine
Published: September 21, 2015
Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
Journal: International journal of clinical and experimental pathology
Published: July 29, 2015
Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.
Journal: International journal of clinical and experimental medicine
Published: July 25, 2015
NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Journal: International journal of clinical and experimental pathology
Published: January 27, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026